Biotech

- Advertisement -
Ad imageAd image
Takeda Commits Over $1.7 Billion to AI-Driven Drug Discovery in Major Partnership with Iambic

One of Japan's largest pharmaceutical companies, Takeda Pharmaceutical Company, has ramped up the use of AI in drug research through a multi, year partnership with AI biotech, Iambic Therapeutics, whose…

RevolKa Raises $1.4M in Series A Extension for Therapies

RevolKa Ltd., a venture-backed biotech company providing a cutting-edge AI-driven protein engineering…

Fujifilm Finds Cancer Targeting Potential in New Peptides

FUJIFILM Corporation announces the successful validation of the cancer cell-targeting potential of…

Asahi Kasei and PeptiSystems Team Up on Peptide Tech

Asahi Kasei Bioprocess America (AKBA) and PeptiSystems have formed an exclusive global…

Sysmex, Gaudi Clinical Form Strategic Business Alliance

Sysmex Corporation and Gaudi Clinical Inc., have signed an agreement. This agreement…

AriBio and Fujirebio Diagnostics Completes Sample Set

Fujirebio Holdings Inc., its wholly-owned subsidiary Fujirebio Diagnostics, Inc., and AriBio Co.,…

Asada Clinic, IBM Japan Develop AI Chatbot for Infertility

Asada Ladies Clinic and IBM Japan announced that they had jointly developed…

Amprat and Digzyme Partner on Data and Enzyme Tech

Amplat Inc. is pleased to announce that it has begun a collaboration…

Nuclera Expand Distribution Across APAC and Middle East

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop…

- Advertisement -
Ad imageAd image

Join Our Community

Join Our Community